A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.
Peroneal electrical transcutaneous neuromodulation is found safe and effective in OAB
"The results of this study demonstrate that peroneal eTNM using the URIS neuromodulation system is safe, well tolerated, and effective, with over 85% of patients experiencing clinically significant improvement in most bothersome OAB symptoms," says Jan Krhut, PhD.
Speaking of Urology: ASCO GU 2023 Highlights
Laura Bukavina, MD, and Kyle Rose, MD, discuss some of the notable abstracts from the 2023 ASCO GU conference.
Study analyzes Twitter representation among academic urologists
Urologic oncology represented the largest subspecialty on Twitter with 225 active members and the highest followers, likes, and tweets per day.
Dr. Katherine Rotker on destigmatizing sexual health
"I think there's a lot of fear that can go into talking about these topics," says Katherine Rotker, MD.
ED visits and hospital admissions continue to rise up to 120 days after stone procedures
The highest cumulative 120-day rates of ED visits and HA were observed in patients who underwent percutaneous nephrolithotomy procedures.
New studies and specialty clinics at University Hospitals look at FPMRS, OAB, and more
"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.
2 Clarke Drive Cranbury, NJ 08512